Begin main content

Dapagliflozin

Last Updated: August 7, 2015
Result type: Reports
Project Number: SR0445-000
Product Line: Common Drug Review

Generic Name: Dapagliflozin

Brand Name: Forxiga

Manufacturer: AstraZeneca Canada Inc.

Indications: Diabetes mellitus, type 2

Submission Type: New Indication

Project Status: Active

Date Recommendation Issued: April 27, 2016

Recommendation Type: Do not list

Tags

metformin, sulfonylurea compounds, diabetes